Showing results (151-160 of 166) with videos related to
Sort By:
Pageof 17
Leukemia|August 30, 2002
F-MuLV acceleration of myelomonocytic tumorigenesis in SV40 large T antigen transgenic mice is accompanied by retroviral insertion at Fli1 and a novel locus, Fim4J Kone, J Arroyo, T Savinelli, et al.Journal of Medicinal Chemistry|October 17, 2022
Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary AngioedemaRebecca L Davie, Hannah J Edwards, D Michael Evans, et al.Genome Research|January 13, 2001
A SNP resource for human chromosome 22: extracting dense clusters of SNPs from the genomic sequenceE Dawson, Y Chen, S Hunt, et al.Human Molecular Genetics|March 1, 1997
Disruption of the clathrin heavy chain-like gene (CLTCL) associated with features of DGS/VCFS: a balanced (21;22)(p12;q11) translocationS E Holmes, M A Riazi, W Gong, et al.Blood Cells, Molecules & Diseases|October 29, 1998
Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical regionA Poltorak, I Smirnova, X He, et al.Gynecologic Oncology|May 1, 2022
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometriumC G Jackson, K N Moore, L Cantrell, et al.Gynecologic Oncology|January 4, 2021
A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancerL R Duska, C N Krasner, D M O'Malley, et al.Gynecologic Oncology|November 6, 2025
Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovaryC Washington, Shailendra Kumar Dhar Dwivedi, C Gunderson-Jackson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2017
Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factorsJ McGee, M Bookman, P Harter, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|October 1, 2017
Editor's Highlight: Pulmonary Vascular Thrombosis in Rats Exposed to Inhaled Sulfur MustardMatthew D McGraw, Christopher M Osborne, Emily J Mastej, et al.Pageof 17